Work

Abstract C085: Discovery and Preclinical Development of Best-in-Class Superpotent Superselective mTOR Inhibitors for Cancer Treatment

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-c085

Authors: Álvaro Lorente-Macias, Jonathon Mok, Margaret C. Frame, Asier Unciti-Broceta

Institution: University of Edinburgh

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444325

Cites:

Cited by:

Related to: